Related Experiment Video

Updated: Aug 17, 2026

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
08:50

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants

Published on: December 14, 2014

The healthy responder phenomenon in non-randomized clinical trials. CAST Investigators

A P Hallstrom1, H L Greene, M L Huther

  • 1CAST Coordinating Center, Department of Biostatistics, University of Washington, Seattle 98105.

Statistics in Medicine
|October 1, 1991
PubMed

Insights

The Cardiac Arrhythmia Suppression Trial (CAST) highlights the "healthy responder" bias, where treatment success in observational studies may appear real but is not. Randomized trials are crucial for accurately demonstrating drug effects.

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Cardiology

Background:

  • Observational studies can suggest treatment benefits due to the 'healthy responder' phenomenon.
  • This bias occurs when patients who respond to treatment are inherently healthier.
  • The Cardiac Arrhythmia Suppression Trial (CAST) provides a unique case study.

Purpose of the Study:

  • To illustrate the 'healthy responder' phenomenon using data from the Cardiac Arrhythmia Suppression Trial (CAST).
  • To explain how this phenomenon can create an apparent, but not real, treatment benefit in observational research.
  • To emphasize the necessity of randomized controlled trials for valid drug effect evaluation.

Main Methods:

  • Utilized the Cardiac Arrhythmia Suppression Trial (CAST) design, which included a pre-randomization titration phase.
  • Analyzed the study data as both a non-randomized and a randomized trial to demonstrate the bias.
  • Examined the impact of patient response on perceived treatment efficacy.

Main Results:

  • The 'healthy responder' phenomenon was clearly illustrated by the CAST data.
  • Apparent treatment benefits were observed in non-randomized analyses due to healthier responders.
  • Randomization is essential to control for this confounding factor.

Conclusions:

  • Randomized trials are indispensable for accurately demonstrating a true drug effect.
  • The 'healthy responder' bias can lead to erroneous conclusions in non-randomized studies.
  • Careful study design, including randomization, is critical in clinical research.

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults06:13

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults

Published on: December 1, 2023

Related Concept Videos

What is an Experiment?01:12

What is an Experiment?

An experiment is a planned activity carried out under controlled conditions. The purpose of an experiment is to investigate the relationship between two variables. When one variable causes change in another, we call the first variable the explanatory or independent variable. The affected variable is called the response or dependent variable. In a randomized experiment, the researcher manipulates values of the explanatory variable and measures the resulting changes in the response variable. The...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...